Acute antihypertensive action of nitroxides in the spontaneously hypertensive rat. 2006

Kinjal Patel, and Yifan Chen, and Kathryn Dennehy, and Jonathan Blau, and Stephanie Connors, and Margarida Mendonca, and Margaret Tarpey, and Murali Krishna, and James B Mitchell, and William J Welch, and Christopher S Wilcox
Georgetown University, Division of Nephrology and Hypertension, 3800 Reservoir Rd., NW, PHC F6003, Washington, DC 20007, USA. wilcoxch@georgetown.edu

Tempol is an amphipathic radical nitroxide (N) that acutely reduces blood pressure (BP) and heart rate (HR) in the spontaneously hypertensive rat (SHR). We investigated the hypothesis that the response to nitroxides is determined by SOD mimetic activity or lipophilicity. Groups (n = 6-10) of anesthetized SHRs received graded intravenous doses of Ns: tempol (T), 4-amino-tempo (AT), 4-oxo-tempo (OT), 4-trimethylammonium-2,2,6,6-tetramethylpiperidine-1-oxyl iodide (CAT-1), 3-carbamoyl-proxyl (3-CP), or 3-carboxy-proxyl (3-CTPY). Others received native or liposomal (L) Cu/Zn SOD. T and OT are uncharged, AT is positively charged and cell-permeable, and CAT-1 is positively charged and cell-impermeable. 3-CP and 3-CTPY have five-member pyrrolidine rings, whereas T, AT, OT, and CAT-1 have six-member piperidine rings. T and AT reduced mean arterial pressure (MAP) similarly (-48 +/- 2 mmHg and -55 +/- 8 mmHg) but more (P < 0.05) than OT and CAT-1. 3-CP and 3-CTPY were ineffective. The group mean change in MAP with piperidine Ns correlated with SOD activity (r = -0.94), whereas their ED(50) correlated with lipophilicity (r = 0.89). SOD and L-SOD did not lower BP acutely but reduced it after 90 min (-32 +/- 5 and -31 +/- 6 mmHg; P < 0.05 vs. vehicle). Pyrrolidine nitroxides are ineffective antihypertensive agents. The antihypertensive response to piperidine Ns is predicted by SOD mimetic action, and the sensitivity of response is by hydrophilicity. SOD exerts a delayed hypotensive action that is not enhanced by liposome encapsulation, suggesting it must diffuse to an extravascular site.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D011918 Rats, Inbred SHR A strain of Rattus norvegicus with elevated blood pressure used as a model for studying hypertension and stroke. Rats, Spontaneously Hypertensive,Rats, SHR,Inbred SHR Rat,Inbred SHR Rats,Rat, Inbred SHR,Rat, SHR,Rat, Spontaneously Hypertensive,SHR Rat,SHR Rat, Inbred,SHR Rats,SHR Rats, Inbred,Spontaneously Hypertensive Rat,Spontaneously Hypertensive Rats
D003497 Cyclic N-Oxides Heterocyclic compounds in which an oxygen is attached to a cyclic nitrogen. Heterocyclic N-Oxides,Cyclic N Oxides,Heterocyclic N Oxides,N Oxides, Cyclic,N-Oxides, Cyclic,N-Oxides, Heterocyclic,Oxides, Cyclic N
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000959 Antihypertensive Agents Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. Anti-Hypertensive,Anti-Hypertensive Agent,Anti-Hypertensive Drug,Antihypertensive,Antihypertensive Agent,Antihypertensive Drug,Anti-Hypertensive Agents,Anti-Hypertensive Drugs,Anti-Hypertensives,Antihypertensive Drugs,Antihypertensives,Agent, Anti-Hypertensive,Agent, Antihypertensive,Agents, Anti-Hypertensive,Agents, Antihypertensive,Anti Hypertensive,Anti Hypertensive Agent,Anti Hypertensive Agents,Anti Hypertensive Drug,Anti Hypertensive Drugs,Anti Hypertensives,Drug, Anti-Hypertensive,Drug, Antihypertensive,Drugs, Anti-Hypertensive,Drugs, Antihypertensive
D013482 Superoxide Dismutase An oxidoreductase that catalyzes the reaction between SUPEROXIDES and hydrogen to yield molecular oxygen and hydrogen peroxide. The enzyme protects the cell against dangerous levels of superoxide. Hemocuprein,Ag-Zn Superoxide Dismutase,Cobalt Superoxide Dismutase,Cu-Superoxide Dismutase,Erythrocuprein,Fe-Superoxide Dismutase,Fe-Zn Superoxide Dismutase,Iron Superoxide Dismutase,Manganese Superoxide Dismutase,Mn-SOD,Mn-Superoxide Dismutase,Ag Zn Superoxide Dismutase,Cu Superoxide Dismutase,Dismutase, Ag-Zn Superoxide,Dismutase, Cobalt Superoxide,Dismutase, Cu-Superoxide,Dismutase, Fe-Superoxide,Dismutase, Fe-Zn Superoxide,Dismutase, Iron Superoxide,Dismutase, Manganese Superoxide,Dismutase, Mn-Superoxide,Dismutase, Superoxide,Fe Superoxide Dismutase,Fe Zn Superoxide Dismutase,Mn SOD,Mn Superoxide Dismutase,Superoxide Dismutase, Ag-Zn,Superoxide Dismutase, Cobalt,Superoxide Dismutase, Fe-Zn,Superoxide Dismutase, Iron,Superoxide Dismutase, Manganese
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

Kinjal Patel, and Yifan Chen, and Kathryn Dennehy, and Jonathan Blau, and Stephanie Connors, and Margarida Mendonca, and Margaret Tarpey, and Murali Krishna, and James B Mitchell, and William J Welch, and Christopher S Wilcox
January 1987, Clinical and experimental hypertension. Part A, Theory and practice,
Kinjal Patel, and Yifan Chen, and Kathryn Dennehy, and Jonathan Blau, and Stephanie Connors, and Margarida Mendonca, and Margaret Tarpey, and Murali Krishna, and James B Mitchell, and William J Welch, and Christopher S Wilcox
January 1985, Journal of cardiovascular pharmacology,
Kinjal Patel, and Yifan Chen, and Kathryn Dennehy, and Jonathan Blau, and Stephanie Connors, and Margarida Mendonca, and Margaret Tarpey, and Murali Krishna, and James B Mitchell, and William J Welch, and Christopher S Wilcox
September 2001, Hypertension (Dallas, Tex. : 1979),
Kinjal Patel, and Yifan Chen, and Kathryn Dennehy, and Jonathan Blau, and Stephanie Connors, and Margarida Mendonca, and Margaret Tarpey, and Murali Krishna, and James B Mitchell, and William J Welch, and Christopher S Wilcox
January 1970, Clinical pharmacology and therapeutics,
Kinjal Patel, and Yifan Chen, and Kathryn Dennehy, and Jonathan Blau, and Stephanie Connors, and Margarida Mendonca, and Margaret Tarpey, and Murali Krishna, and James B Mitchell, and William J Welch, and Christopher S Wilcox
January 1997, Clinical and experimental hypertension (New York, N.Y. : 1993),
Kinjal Patel, and Yifan Chen, and Kathryn Dennehy, and Jonathan Blau, and Stephanie Connors, and Margarida Mendonca, and Margaret Tarpey, and Murali Krishna, and James B Mitchell, and William J Welch, and Christopher S Wilcox
June 1985, Naunyn-Schmiedeberg's archives of pharmacology,
Kinjal Patel, and Yifan Chen, and Kathryn Dennehy, and Jonathan Blau, and Stephanie Connors, and Margarida Mendonca, and Margaret Tarpey, and Murali Krishna, and James B Mitchell, and William J Welch, and Christopher S Wilcox
June 1996, American journal of hypertension,
Kinjal Patel, and Yifan Chen, and Kathryn Dennehy, and Jonathan Blau, and Stephanie Connors, and Margarida Mendonca, and Margaret Tarpey, and Murali Krishna, and James B Mitchell, and William J Welch, and Christopher S Wilcox
August 1976, Neuropharmacology,
Kinjal Patel, and Yifan Chen, and Kathryn Dennehy, and Jonathan Blau, and Stephanie Connors, and Margarida Mendonca, and Margaret Tarpey, and Murali Krishna, and James B Mitchell, and William J Welch, and Christopher S Wilcox
January 1987, Journal of cardiovascular pharmacology,
Kinjal Patel, and Yifan Chen, and Kathryn Dennehy, and Jonathan Blau, and Stephanie Connors, and Margarida Mendonca, and Margaret Tarpey, and Murali Krishna, and James B Mitchell, and William J Welch, and Christopher S Wilcox
January 1993, The Journal of pharmacology and experimental therapeutics,
Copied contents to your clipboard!